Not approved for women
The Propecia label states that the drug is for men only and is not indicated for use in women. That reflects both a safety problem (pregnancy) and a lack of proof that it works. Female pattern hair loss, the gradual thinning over the top of the scalp that many women develop, does not have as clear a link to the hormone DHT as the male form does, so a drug that lowers DHT is not guaranteed to help. Background on DHT is on the how it works page.
Why pregnancy is a strict contraindication
Finasteride is contraindicated in women who are or may become pregnant because it can interfere with the development of a male baby's genitals. DHT is needed for normal formation of male external genitalia, and finasteride blocks DHT production. In animal studies, finasteride given during pregnancy caused abnormalities such as hypospadias (a misplaced urethral opening) in male offspring.
The warning extends to handling. Women who are or may be pregnant should not touch crushed or broken tablets, because the drug may be absorbed through the skin. Intact tablets are coated, which prevents contact during normal handling. If contact with a broken tablet happens, the label says to wash the area right away with soap and water.
Topical finasteride has no protective coating. The FDA has warned that liquid and spray products carry a greater risk of transferring the drug to a partner through contact.
Semen is a much smaller concern. In a study of 35 men taking 1 mg a day, finasteride was undetectable in the semen of 60% of them, and the label calculates that the highest level measured would expose a partner to an amount 650 times lower than a dose that had no effect on DHT in men.
What the studies in postmenopausal women found
The only placebo-controlled trial found that finasteride 1 mg did not work in postmenopausal women. Price and colleagues gave 137 women aged 41 to 60 either finasteride 1 mg or placebo for a year. There was no significant difference in hair count, and patient ratings, investigator ratings, photographs and scalp biopsies showed no improvement over placebo.
Later studies used higher doses but had no placebo group, which makes them much weaker evidence:
- In 87 pre- and postmenopausal Asian women taking 5 mg a day for 12 months, 70 of the 86 who finished (81.4%) were rated improved on photographs, and hair density rose.
- In 37 premenopausal women taking 2.5 mg a day together with an oral contraceptive, 23 (62%) were rated improved at 12 months. The authors could not tell whether the finasteride or the contraceptive, which has its own anti-androgen effect, was responsible.
- A small randomized trial in 30 postmenopausal women compared a topical mix of 0.25% finasteride and 3% minoxidil with 3% minoxidil alone. The combination gave a greater increase in hair diameter, and it also lowered blood DHT, showing the topical drug was absorbed.
How off-label use works
Some dermatologists prescribe finasteride to women off-label, mostly after menopause or alongside reliable contraception. Off-label means using an approved drug for a purpose the FDA has not approved, which is legal. Because of the fetal risk, this is one situation where the decision belongs in a visit with a clinician who knows the patient's pregnancy potential. The doses used in the studies above were higher than the male dose (see dosage), and the evidence for them is uncontrolled.
See also finasteride vs minoxidil and topical finasteride.
Common questions
Can women take finasteride for hair loss?
It is not FDA-approved for women. Some clinicians prescribe it off-label, mainly to postmenopausal women, but the one placebo-controlled trial at 1 mg showed no benefit.
Is it safe to touch finasteride tablets while pregnant?
Whole, coated tablets do not expose you to the drug in normal handling. Crushed or broken tablets should not be handled by anyone who is or may be pregnant.
My partner takes finasteride and we are trying to conceive. Is that a risk to the baby?
The label estimates that exposure through semen is hundreds of times below a level that affects DHT. Fertility effects on the man himself are discussed on the safety page.
Why did the trial in postmenopausal women fail?
The study could not say why. It only showed that 1 mg a day for a year was no better than placebo in that group.
Sources
- Organon. Propecia (finasteride) tablets 1 mg, full prescribing information and patient information. DailyMed, National Library of Medicine. DailyMed: Propecia label
- Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Journal of the American Academy of Dermatology, 2000. PubMed 11050579
- Yeon JH, Jung JY, Choi JW, et al. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. Journal of the European Academy of Dermatology and Venereology, 2011. PubMed 20569283
- Iorizzo M, Vincenzi C, Voudouris S, Piraccini BM, Tosti A. Finasteride treatment of female pattern hair loss. Archives of Dermatology, 2006. PubMed 16549704
- Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study. American Journal of Clinical Dermatology, 2019. PubMed 30206824
- US Food and Drug Administration. FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products, 2025. FDA alert